- Home
- NXTC vs TCBS Comparison
NXTC vs TCBS Comparison
Compare NXTC & TCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXTC
- TCBS
- Stock Information
- Founded
- NXTC 2015
- TCBS 1934
- Country
- NXTC United States
- TCBS United States
- Employees
- NXTC N/A
- TCBS N/A
- Industry
- NXTC Biotechnology: Pharmaceutical Preparations
- TCBS Banks
- Sector
- NXTC Health Care
- TCBS Finance
- Exchange
- NXTC Nasdaq
- TCBS Nasdaq
- Market Cap
- NXTC 40.3M
- TCBS 45.5M
- IPO Year
- NXTC 2019
- TCBS N/A
- Fundamental
- Price
- NXTC $1.42
- TCBS $14.36
- Analyst Decision
- NXTC Strong Buy
- TCBS
- Analyst Count
- NXTC 2
- TCBS 0
- Target Price
- NXTC $6.00
- TCBS N/A
- AVG Volume (30 Days)
- NXTC 23.4K
- TCBS 5.5K
- Earning Date
- NXTC 10-31-2024
- TCBS 08-13-2024
- Dividend Yield
- NXTC N/A
- TCBS 1.11%
- EPS Growth
- NXTC N/A
- TCBS N/A
- EPS
- NXTC N/A
- TCBS N/A
- Revenue
- NXTC N/A
- TCBS $9,785,000.00
- Revenue This Year
- NXTC N/A
- TCBS N/A
- Revenue Next Year
- NXTC N/A
- TCBS N/A
- P/E Ratio
- NXTC N/A
- TCBS N/A
- Revenue Growth
- NXTC N/A
- TCBS N/A
- 52 Week Low
- NXTC $0.98
- TCBS $11.78
- 52 Week High
- NXTC $2.57
- TCBS $15.24
- Technical
- Relative Strength Index (RSI)
- NXTC 34.28
- TCBS 65.91
- Support Level
- NXTC $1.41
- TCBS $13.70
- Resistance Level
- NXTC $1.65
- TCBS $14.41
- Average True Range (ATR)
- NXTC 0.09
- TCBS 0.10
- MACD
- NXTC -0.02
- TCBS 0.08
- Stochastic Oscillator
- NXTC 14.81
- TCBS 92.18
About NXTC NextCure Inc.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases, and NC181, for Alzheimer's disease.
About TCBS Texas Community Bancshares Inc.
Texas Community Bancshares Inc is a holding company. The company's business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank of Dallas, in residential real estate loans and commercial real estate loans and, to a lesser extent, commercial loans, construction and land loans, and consumer and other loans. Its portfolio segments are real estate, agriculture, commercial, consumer and other.